Alexander Boiko, general manager of Novo Nordisk Ukraine, provides insights into the recent progress and remaining room for improvement in Ukraine’s health capacity when it comes to preventing, diagnosing, and treating diabetes, as well as the company’s unique commitment to partner with the government at the moment an unprecedented set of reforms aims to further enhance the country’s overall health system.
You set up Novo Nordisk’s Ukrainian affiliate in 1993, which means you have been a privileged witness to the modern history of Ukraine’s health system. What is your assessment of the country’s diabetes capacity and its evolution?
"Beside very recent initiatives, no significant health reform has been implemented over the 25 years that followed our country’s independence in 1991, and our country’s health outcomes have been worryingly decreasing since the Soviet era."
